PathAI CEO and co-founder Andrew Beck said: “Skin cancer remains the most prevalent cancer worldwide, with over 1.5 million new cases diagnosed annually, which are associated with 60,000 deaths ...

Beck is the cofounder of PathAI, a Boston company at the interface of artificial intelligence and medical diagnostics. PathAI builds machine learning models that can spot signs of disease or help ...

PathAI co-founder and CEO Andy Beck said: “Rede D’Or’s commitment to innovation in healthcare as a means to improve patient outcomes makes them the ideal partner for introducing our ...

co-founder and CEO of PathAI. “Rede D’Or’s commitment to innovation in healthcare as a means to improve patient outcomes makes them the ideal partner for introducing our technology to the ...

“We are excited to partner with Discovery Life Sciences to revolutionize the biospecimens industry,” said Andy Beck, CEO of PathAI. “Our digital pathology solutions will enable Discovery ...

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and support new ...

co-founder and CEO of PathAI. "Rede D'Or's commitment to innovation in healthcare as a means to improve patient outcomes makes them the ideal partner for introducing our technology to the Latin ...